Back
Phathom Pharmaceuticals Stock Predictions
Sponsored
PHAT
Sponsored
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
60
PHAT
Phathom Pharmaceuticals
Last Price:
18.76
Seasonality Move:
-9.67%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Phathom Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Phathom Pharmaceuticals has on average historically fallen by 0.9% based on the past 4 years of stock performance.
- Phathom Pharmaceuticals has fallen lower in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Phathom Pharmaceuticals Stock Undervalued?
The current Phathom Pharmaceuticals [PHAT] share price is $18.69. The Score for PHAT is 60, which is 20% above its historic median score of 50, and infers lower risk than normal. - PHAT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Phathom Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Phathom Pharmaceuticals has on average historically fallen by 0.9% based on the past 4 years of stock performance.
Phathom Pharmaceuticals Stock Rating
Buy
60
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals overpriced?
- Phathom Pharmaceuticals has fallen lower in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Phathom Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
phathompharma.com
52-Week Data
52-Week High:
19.71
52-Week Low:
6.07
Prediction Charts
Market Cap:
1.28B
Price in USD:
18.69
Volume:
1.27M
Beta:
0.72
Technical Analysis
SMA50:
13.94
SMA100:
12.17
SMA200:
10.51
52-Wk Change:
68.68%
Stock Predictions
-
Is Phathom Pharmaceuticals stock public?
Yes, Phathom Pharmaceuticals is a publicly traded company. -
What is the Phathom Pharmaceuticals stock quote today?
The Phathom Pharmaceuticals stock price is 18.69 USD today. -
How to buy Phathom Pharmaceuticals stock online?
You can buy Phathom Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Aug-30 | 16.30 | 16.52 | 16.95 | 15.79 |
Sep-3 | 16.54 | 16.24 | 16.74 | 15.73 |
Sep-4 | 16.23 | 17.00 | 17.06 | 15.90 |
Sep-5 | 17.25 | 17.95 | 18.58 | 16.95 |
Sep-6 | 17.78 | 17.70 | 17.99 | 17.41 |
Sep-9 | 17.59 | 17.58 | 17.90 | 17.32 |
Sep-10 | 17.58 | 17.91 | 18.06 | 16.76 |
Sep-11 | 17.88 | 18.70 | 18.71 | 17.74 |
Sep-12 | 18.70 | 19.51 | 19.68 | 18.68 |
Sep-13 | 19.67 | 18.30 | 19.67 | 18.19 |
Sep-16 | 18.34 | 18.89 | 19.10 | 17.86 |
Sep-17 | 19.00 | 18.49 | 19.13 | 18.32 |
Sep-18 | 18.52 | 19.25 | 19.54 | 18.31 |
Sep-19 | 19.63 | 18.69 | 19.71 | 18.40 |
Phathom Pharmaceuticals Earnings
Phathom Pharmaceuticals Earnings Report: Per Share Phathom Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Phathom Pharmaceuticals Forecast Revenue Growth
Phathom Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Phathom Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.50 per share, an increase next quarter of $0.54 per share, a decrease this year of $1.71 per share, and an increase next year of $1.35 per share.
* Phathom Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.